Last news
HNS 2026 | Huawei Unveils Upgraded Xinghe AI Campus Solution for Southern Africa

HNS 2026 | Huawei Unveils Upgraded Xinghe AI Campus Solution for Southern Africa

JOHANNESBURG, July 27, 2026 /PRNewswire/ -- At the Huawei Network Summit 2026 South Africa, Huawei unveiled its upgraded Xinghe AI Campus Solution for the Southern Africa region under the "Secure and Intelligent Connectivity" philosophy, and also...

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today...

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater sensitivity vs. in-class instruments with lower...

BASF Agricultural Solutions starts global registration of novel PPO herbicide Replexor™ Active

BASF Agricultural Solutions starts global registration of novel PPO herbicide Replexor™ Active

Regulatory dossiers for Replexor Active submitted in Brazil and Australia; US and Argentina to follow in 2027 Rounding out weed control spectrum, Replexor Active strengthens integrated PPO herbicide portfolio, helping growers maximize the value of...

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway Global Phase 1 multicenter study evaluates safety, tolerability, and preliminary efficacy in patients with mesothelioma...

Air Premia Expands U.S.-Asia Connectivity Through Interline Partnership with Jeju Air

Air Premia Expands U.S.-Asia Connectivity Through Interline Partnership with Jeju Air

Expanded Network: The interline partnership seamlessly connects Air Premia's long-haul U.S. routes with cities across more than 40 countries served by Jeju Air. Seamless Travel: Single-ticket itineraries enhance passenger convenience; joint travel...

HTCO Announces Ten-Year Extension of Singapore MSI-AIS Maritime Tax Exemption Through 2035

HTCO Announces Ten-Year Extension of Singapore MSI-AIS Maritime Tax Exemption Through 2035

MSI-AIS Award Extended Through 2035, Providing Long-Term Tax Certainty and Enhancing Competitive Position in Global Shipping NEW YORK, July 27, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global...

Ohmyhome Ltd Announces Pricing of $4 Million Registered Direct Offering

Ohmyhome Ltd Announces Pricing of $4 Million Registered Direct Offering

SINGAPORE, July 27, 2026 /PRNewswire/ -- Ohmyhome Ltd (NASDAQ: OMH) (the "Company"), a data- and technology-driven digital marketing company delivering multi-channel marketing and content solutions for advertisers, today announced that it has...

1 2 3 4 5 6 7 8 9 10 ... 5108
menu
menu